"Receptors, IgG" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Specific molecular sites on the surface of various cells, including B-lymphocytes and macrophages, that combine with IMMUNOGLOBULIN Gs. Three subclasses exist: Fc gamma RI (the CD64 antigen, a low affinity receptor), Fc gamma RII (the CD32 antigen, a high affinity receptor), and Fc gamma RIII (the CD16 antigen, a low affinity receptor).
Descriptor ID |
D017452
|
MeSH Number(s) |
D12.776.543.750.705.871.300
|
Concept/Terms |
Receptors, IgG- Receptors, IgG
- IgG Receptors
- gamma Fc Receptors
- Fc gamma Receptors
- gamma Receptors, Fc
- Receptors, Fc gamma
- Immunoglobulin G Receptor
- Receptor, Immunoglobulin G
- Fc Receptors, gamma
- Receptors, gamma Fc
CD32 Antigens- CD32 Antigens
- CD 32 Antigens
- Antigens, CD 32
- Fc gamma RII
- gamma RII, Fc
- Antigens, CD32
CD64 Antigens- CD64 Antigens
- CD 64 Antigens
- Antigens, CD 64
- Fc gamma RI
- gamma RI, Fc
- Antigens, CD64
Antigens, CD16- Antigens, CD16
- Fc gamma RIII
- gamma RIII, Fc
- CD 16 Antigens
- Antigens, CD 16
- CD16 Antigens
|
Below are MeSH descriptors whose meaning is more general than "Receptors, IgG".
Below are MeSH descriptors whose meaning is more specific than "Receptors, IgG".
This graph shows the total number of publications written about "Receptors, IgG" by people in this website by year, and whether "Receptors, IgG" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1999 | 0 | 3 | 3 |
2000 | 1 | 1 | 2 |
2002 | 1 | 0 | 1 |
2005 | 1 | 3 | 4 |
2006 | 1 | 3 | 4 |
2007 | 2 | 1 | 3 |
2008 | 2 | 2 | 4 |
2009 | 2 | 1 | 3 |
2010 | 1 | 3 | 4 |
2011 | 1 | 5 | 6 |
2012 | 0 | 3 | 3 |
2013 | 2 | 0 | 2 |
2014 | 2 | 0 | 2 |
2015 | 3 | 2 | 5 |
2017 | 1 | 1 | 2 |
2018 | 0 | 3 | 3 |
2019 | 1 | 4 | 5 |
2020 | 2 | 0 | 2 |
2021 | 1 | 2 | 3 |
2022 | 1 | 0 | 1 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Receptors, IgG" by people in Profiles.
-
Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial. Cancer Immunol Immunother. 2023 Jul; 72(7):2099-2111.
-
Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity. EBioMedicine. 2022 Dec; 86:104343.
-
STAT3 Gain-of-Function Mutations Underlie Deficiency in Human Nonclassical CD16+ Monocytes and CD141+ Dendritic Cells. J Immunol. 2021 11 15; 207(10):2423-2432.
-
Combining AFM13, a Bispecific CD30/CD16 Antibody, with Cytokine-Activated Blood and Cord Blood-Derived NK Cells Facilitates CAR-like Responses Against CD30+ Malignancies. Clin Cancer Res. 2021 07 01; 27(13):3744-3756.
-
CD8+CD161+ T-Cells: Cytotoxic Memory Cells With High Therapeutic Potential. Front Immunol. 2020; 11:613204.
-
Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody. Proc Natl Acad Sci U S A. 2020 08 04; 117(31):18754-18763.
-
Quantifying the contribution of Fc-mediated effector functions to the antiviral activity of anti-HIV-1 IgG1 antibodies in vivo. Proc Natl Acad Sci U S A. 2020 07 28; 117(30):18002-18009.
-
Supplementation With the Sialic Acid Precursor N-Acetyl-D-Mannosamine Breaks the Link Between Obesity and Hypertension. Circulation. 2019 12 10; 140(24):2005-2018.
-
Characterization and Comparison of GITR Expression in Solid Tumors. Clin Cancer Res. 2019 11 01; 25(21):6501-6510.
-
TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletion. Proc Natl Acad Sci U S A. 2019 05 21; 116(21):10453-10462.